This clinical trial aims to evaluate the effectiveness of a new treatment for managing chronic pain. Participants will be randomly assigned to receive either the experimental treatment or a placebo. The study will monitor changes in pain levels and overall health over a 12-week period.
- Who Can Participate:
- Adults aged 18-65 with a diagnosis of chronic pain for at least 6 months
- Must not have any other significant health conditions
- Study Details:
- Participants will receive either the new treatment or a placebo
- The study will last for 12 weeks, with regular health assessments
- Study Timelines and Visits: The study is expected to start in January 2024 and conclude by April 2024.Participants will need to attend 5 visits over the course of the study